Biogen Idec (BIIB) volatility flat shares near record high

Biogen Idec (Nasdaq: BIIB) overall option implied volatility of 29 is below its 26-week average of 32 according to Track Data, suggesting decreasing price movement. Deutsche Bank has a Buy rating and a $129 price target on the company.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Biogen (BIIB) call put ratio 3.7 calls to 1 put with a focus on September calls
• Sandisk (SNDK) call put ratio 1.2 calls to 1 put
• Western Digital (WDC) call put ratio 1 call to 1 put as share price down 1.3%